Clinical Trial Update: Target of Suv420h1/2 in Hepatocytes [NA]

View source ↗

Summary

A recruiting clinical trial is investigating inhibition of Suv420h1/2 in hepatocytes for non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: NAFLD | NA | Status: RECRUITING